BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
Keyword: fatty liver
1
Liver function improvement after human placental extract injections in patients with chronic liver disease: Thirty case reports
6/4/2025 7:41:49 AM | Browse: 10 | Download: 48
2
Establishment and validation of an adherence prediction system for lifestyle interventions in non-alcoholic fatty liver disease
3/14/2024 5:31:16 PM | Browse: 175 | Download: 732
3
Fatty liver and celiac disease: Why worry?
5/24/2023 9:31:05 AM | Browse: 251 | Download: 611
4
Diabetes and fatty liver: Involvement of incretin and its benefit for fatty liver management
5/15/2023 3:23:22 PM | Browse: 243 | Download: 668
5
In vivo recognition of bioactive substances of Polygonum multiflorum for protecting mitochondria against metabolic dysfunction-associated fatty liver disease
1/4/2023 5:53:02 AM | Browse: 301 | Download: 874
6
Combination strategies for pharmacologic treatment of non-alcoholic steatohepatitis
9/15/2022 1:37:25 PM | Browse: 410 | Download: 858
7
How to select the quantitative magnetic resonance technique for subjects with fatty liver: A systematic review
8/26/2022 9:54:52 AM | Browse: 311 | Download: 798
8
Higher cardiovascular risk scores and liver fibrosis risk estimated by biomarkers in patients with metabolic-dysfunction-associated fatty liver disease
8/26/2022 9:51:35 AM | Browse: 437 | Download: 860
9
Factors early in life associated with hepatic steatosis
6/23/2022 2:39:01 PM | Browse: 485 | Download: 1155
10
Application of artificial intelligence in non-alcoholic fatty liver disease and viral hepatitis
4/29/2022 11:12:04 AM | Browse: 554 | Download: 901
11
Promising diagnostic biomarkers of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: From clinical proteomics to microbiome
11/24/2021 9:54:22 AM | Browse: 523 | Download: 1138
12
Machine learning models for predicting non-alcoholic fatty liver disease in the general United States population: NHANES database
10/22/2021 1:53:28 PM | Browse: 577 | Download: 1322
13
Standard liver weight model in adult deceased donors with fatty liver: A prospective cohort study.
10/20/2021 7:18:39 AM | Browse: 464 | Download: 948
14
Impact of COVID-19 on liver
9/16/2021 8:48:21 AM | Browse: 484 | Download: 760
15
Association of non-alcoholic fatty liver disease and COVID-19: A literature review of current evidence
8/20/2021 9:33:19 AM | Browse: 752 | Download: 1463
16
Prevalence and risk factors of steatosis and advanced fibrosis using transient elastography in the United States’ adolescent population
7/23/2021 8:10:13 AM | Browse: 630 | Download: 1314
17
Non-alcoholic fatty liver disease and COVID-19: An epidemic that begets pandemic
5/26/2021 9:58:01 AM | Browse: 516 | Download: 978
18
Metabolic complications of hepatitis C virus infection
3/30/2021 7:03:44 AM | Browse: 562 | Download: 1096
19
Effects of proprotein convertase subtilisin/kexin type-9 inhibitors on fatty liver
12/18/2020 5:58:43 AM | Browse: 783 | Download: 1422
20
Metabolic associated fatty liver disease: Addressing a new era in liver transplantation
12/18/2020 5:58:43 AM | Browse: 805 | Download: 1238
21
Fatty liver is an independent risk factor for gallbladder polyps
11/27/2020 9:27:48 AM | Browse: 762 | Download: 1749
22
Cannabis use history is associated with increased prevalence of ascites among patients with nonalcoholic fatty liver disease: A nationwide analysis
11/24/2020 12:41:21 PM | Browse: 686 | Download: 1749
23
Relationship between non-alcoholic fatty liver disease and coronary heart disease
10/26/2020 9:59:39 AM | Browse: 722 | Download: 1245
24
Can gadoxetic acid–enhanced magnetic resonance imaging be used to avoid liver biopsy in patients with nonalcoholic fatty liver disease?
9/21/2020 4:02:08 PM | Browse: 598 | Download: 1969
25
Glucagon-like peptide-1 receptor agonists in non-alcoholic fatty liver disease: An update
8/25/2020 9:16:00 AM | Browse: 728 | Download: 1419
26
Medications in type-2 diabetics and their association with liver fibrosis
6/21/2020 2:15:44 PM | Browse: 720 | Download: 1348
27
Non-alcoholic fatty liver disease and Atherosclerosis at a crossroad: The overlap of a theory of change and bioinformatics
5/12/2020 3:08:42 AM | Browse: 829 | Download: 1347
28
Comparison of four non-alcoholic fatty liver disease detection scores in a Caucasian population
4/23/2020 10:34:55 AM | Browse: 837 | Download: 1656
29
Single strain probiotics for dyslipidemia, fatty liver, and obesity: A systematic review and meta-analysis
6/30/2019 3:51:24 AM | Browse: 1176 | Download: 2163
30
C-peptide as a key risk factor for non-alcoholic fatty liver disease in the United States population
8/27/2018 7:22:43 AM | Browse: 1147 | Download: 1726
31
Liver intravoxel incoherent motion diffusion-weighted imaging for the assessment of hepatic steatosis and fibrosis in children
7/19/2018 7:04:34 AM | Browse: 1149 | Download: 2053
32
Digital liver biopsy: Bio-imaging of fatty liver for translational and clinical research
3/4/2018 12:36:47 PM | Browse: 1531 | Download: 1710
33
Fatty liver disease, an emerging etiology of hepatocellular carcinoma in Argentina
1/26/2018 8:09:36 AM | Browse: 1292 | Download: 1818
34
Clinical epidemiology and disease burden of nonalcoholic fatty liver disease
12/20/2017 2:49:19 AM | Browse: 1436 | Download: 1746
35
Antioxidant dietary approach in treatment of fatty liver: New insights and updates
6/20/2017 12:12:52 PM | Browse: 1183 | Download: 2080
36
Coffee: The magical bean for liver diseases
5/19/2017 9:53:34 AM | Browse: 1293 | Download: 1775
37
Three-dimensional perfused human in vitro model of non-alcoholic fatty liver disease
1/12/2017 1:49:00 PM | Browse: 1778 | Download: 1731
38
Mitochondrial carnitine palmitoyl transferase-Ⅱ inactivity aggravates lipid accumulation in rat hepatocarcinogenesis
1/12/2017 1:49:00 PM | Browse: 1400 | Download: 1955
39
Fatty liver is associated with an increased risk of diabetes and cardiovascular disease - Evidence from three different disease models: NAFLD, HCV and HIV
11/26/2016 6:56:00 PM | Browse: 1390 | Download: 1865
40
Neglected features of lifestyle: Their relevance in non-alcoholic fatty liver disease
11/25/2016 9:02:00 AM | Browse: 1413 | Download: 2342
41
Hepatocellular carcinoma in patients with non-alcoholic fatty liver disease
9/30/2016 5:59:00 PM | Browse: 1335 | Download: 1692
42
Iron and non-alcoholic fatty liver disease
9/26/2016 8:04:00 AM | Browse: 1362 | Download: 1773
43
Steatotic livers are susceptible to normothermic ischemia-reperfusion injury from mitochondrial Complex-Ⅰ dysfunction
5/19/2016 9:54:00 AM | Browse: 1116 | Download: 2373
44
Probiotics as a complementary therapeutic approach in nonalcoholic fatty liver disease
12/2/2015 12:01:00 PM | Browse: 1464 | Download: 1697
45
Dietary supplements and pediatric non-alcoholic fatty liver disease: Present and the future
11/9/2015 6:35:00 PM | Browse: 1320 | Download: 1879
46
Dietary approach in the treatment of nonalcoholic fatty liver disease
10/30/2015 11:57:00 AM | Browse: 1042 | Download: 1714
47
Female spontaneously diabetic Torii fatty rats develop nonalcoholic steatohepatitis-like hepatic lesions
8/17/2015 11:14:00 AM | Browse: 1134 | Download: 2351
48
Physical activity as a treatment of non-alcoholic fatty liver disease: A systematic review
8/8/2015 2:17:00 PM | Browse: 1537 | Download: 2053
49
Altered distribution of regulatory lymphocytes by oral administration of soy-extracts exerts a hepatoprotective effect alleviating immune mediated liver injury, non-alcoholic steatohepatitis and insulin resistance
6/29/2015 4:40:00 PM | Browse: 1222 | Download: 1544
50
Non-alcoholic fatty liver disease in 2015
6/16/2015 2:22:00 PM | Browse: 1274 | Download: 1995
Write to the Help Desk
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345